GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Gross Profit

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Gross Profit : $22.94 Mil (TTM As of Mar. 2017)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Gross Profit?

Aoxing Pharmaceutical Co's gross profit for the three months ended in Mar. 2017 was $4.42 Mil. Aoxing Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2017 was $22.94 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Aoxing Pharmaceutical Co's gross profit for the three months ended in Mar. 2017 was $4.42 Mil. Aoxing Pharmaceutical Co's Revenue for the three months ended in Mar. 2017 was $5.70 Mil. Therefore, Aoxing Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2017 was 77.53%.

Aoxing Pharmaceutical Co had a gross margin of 77.53% for the quarter that ended in Mar. 2017 => Durable competitive advantage


Aoxing Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Gross Profit Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.90 6.27 5.81 19.79 24.55

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.93 6.16 6.05 6.30 4.42

Competitive Comparison of Aoxing Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxing Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Gross Profit falls into.



Aoxing Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Aoxing Pharmaceutical Co's Gross Profit for the fiscal year that ended in Jun. 2016 is calculated as

Gross Profit (A: Jun. 2016 )=Revenue - Cost of Goods Sold
=32.33 - 7.776
=24.55

Aoxing Pharmaceutical Co's Gross Profit for the quarter that ended in Mar. 2017 is calculated as

Gross Profit (Q: Mar. 2017 )=Revenue - Cost of Goods Sold
=5.702 - 1.281
=4.42

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.94 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Aoxing Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2017 is calculated as

Gross Margin % (Q: Mar. 2017 )=Gross Profit (Q: Mar. 2017 ) / Revenue (Q: Mar. 2017 )
=(Revenue - Cost of Goods Sold) / Revenue
=4.42 / 5.702
=77.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Aoxing Pharmaceutical Co had a gross margin of 77.53% for the quarter that ended in Mar. 2017 => Durable competitive advantage


Aoxing Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines